(Q33287060)

English

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

macular degeneration

1 reference

based on heuristic

inferred from title

object named as

Hamid Ahmadieh

1

1 reference

ORCID Public Data File 2021

author name string

Ramin Taei

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Masoud Soheilian

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Mohammad Riazi-Esfahani

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Reza Karkhaneh

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Alireza Lashay

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Mohsen Azarmina

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Mohammad Hossein Dehghan

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Siamak Moradian

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

7 June 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

BMC Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

7 June 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904176

21 June 2018

Intravitreal triamcinolone reinjection for refractory diabetic macular edema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904176

21 June 2018

Triamcinolone acetonide suppresses early proangiogenic response in retinal pigment epithelial cells after photodynamic therapy in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904176

21 June 2018

Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of subfoveal choroidal neovascularisation in age related macular degeneration: a comparative study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904176

21 June 2018

Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904176

21 June 2018

Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904176

21 June 2018

Sequence of Early Vascular Events after Photodynamic Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904176

21 June 2018

Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904176

21 June 2018

Photodynamic effects on choroidal neovascularization and physiological choroid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904176

21 June 2018

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904176

21 June 2018

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904176

21 June 2018

Problems with and pitfalls of photodynamic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904176

21 June 2018

Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1904176

21 June 2018

Time course and morphology of vascular effects associated with photodynamic therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-10

21 January 2018

Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-10

21 January 2018

ICGA-guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Indocyanine green angiography

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-10

21 January 2018

A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-10

21 January 2018

Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-10

21 January 2018

Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-10

21 January 2018

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-10

21 January 2018

Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-10

21 January 2018

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-10

21 January 2018

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therap

1 reference

https://pubmed.ncbi.nlm.nih.gov/17555600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal triamcinolone acetonide in exudative age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17555600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17555600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17555600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for exudative age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17555600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration

1 reference

https://pubmed.ncbi.nlm.nih.gov/17555600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17555600

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2415-7-10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2415-7-10

9 September 2019

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33287060&oldid=2195203266"